RYSYX
Price
$81.19
Change
+$1.20 (+1.50%)
Updated
Aug 22 closing price
Net Assets
163.23M
VTSMX
Price
$154.82
Change
+$2.59 (+1.70%)
Updated
Aug 22 closing price
Net Assets
1.91T
Interact to see
Advertisement

RYSYX vs VTSMX

Header iconRYSYX vs VTSMX Comparison
Open Charts RYSYX vs VTSMXBanner chart's image
Rydex S&P 500 C
Price$81.19
Change+$1.20 (+1.50%)
VolumeN/A
Net Assets163.23M
Vanguard Total Stock Mkt Idx I
Price$154.82
Change+$2.59 (+1.70%)
VolumeN/A
Net Assets1.91T
RYSYX vs VTSMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RYSYX vs. VTSMX commentary
Aug 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYSYX is a Buy and VTSMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.91T vs. RYSYX (163M). VTSMX pays higher dividends than RYSYX: VTSMX (1.09) vs RYSYX (0.17). RYSYX was incepted earlier than VTSMX: RYSYX (19 years) vs VTSMX (33 years). RYSYX (2.41) is less costly to investors than VTSMX (0.14). RYSYX is a more actively managed with annual turnover of: 137.00 vs. VTSMX (2.00). RYSYX has a lower initial minimum investment than VTSMX: RYSYX (2500) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 14.24 vs. RYSYX (11.90). VTSMX return over 5 years is better than : 82.37 vs. RYSYX (48.07).
RYSYXVTSMXRYSYX / VTSMX
Total Expense Ratio2.360.141,686%
Annual Report Gross Expense Ratio2.410.141,721%
Fund Existence19 years33 years-
Gain YTD7.5428.01094%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets163M1.91T0%
Annual Yield % from dividends0.171.0916%
Returns for 1 year11.9014.2484%
Returns for 3 years45.4951.6188%
Returns for 5 years48.0782.3758%
Returns for 10 years131.77234.8356%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FFBC26.551.04
+4.08%
First Financial Bancorp
IBO0.60N/A
+0.76%
Impact BioMedical Inc.
PFX49.500.26
+0.52%
PhenixFIN Corp
RPRX36.320.01
+0.03%
Royalty Pharma plc
RAPP14.77-0.16
-1.07%
Rapport Therapeutics Inc.